KIRKLAND – Rethink Breast Cancer (Rethink) and Pfizer Canada are proud to announce three recipients who will collectively receive over $200,000 in grants for their work in developing innovative strategies to measurably improve the quality of care for people living with metastatic breast cancer (mBC). Guided by the unique and unmet needs identified by people living with mBC and their families, …